About ExactCure
ExactCure is a Healthcare company based in Nice (France) founded in 2016 by Frederic Dayan. AI platform for personalized drug response simulation is provided. ExactCure has raised $1.1 million across 3 funding rounds from investors including EIT Health, European Union and OneRagtime. Its focus areas include HealthTech, Disease Self Management, Medication Adherence and App.
Company details
ExactCure was founded in 2016 in Nice, France, within the health technology sector. An AI-driven platform is being developed to enable patients to track drug behavior in their bodies without invasive diagnostics. Personalized responses are simulated using proprietary algorithms that analyze individual characteristics obtained from questionnaires. Operations focus on precision modeling for therapeutic outcomes in pharmaceutical applications.
- Headquarters Nice, France
- Founders Frederic Dayan
- SectorsHealthcare
- Email••••••••
- Website exactcure.com
- Social LinkedIn X
- Total Equity Funding$1.1M (USD)
in 3 rounds
- Latest Funding Round$748.85K (USD), Grant
Jan 2021
- InvestorsEIT Health
& 2 more
Funding Insights of ExactCure
ExactCure has successfully raised a total of $1.1M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $748.85 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.1M
- Total Rounds 3
- Last Round Grant — $748,851
- First Round $46,807
(Jul 2018)
- Investors Count 3
All 3 funding rounds of ExactCure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $748,851 | Grant | – | – | |
| Nov 2019 | $1.1M | Seed | – | OneRagtime | – |
| Jul 2018 | $46,807 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in ExactCure
ExactCure has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include EIT Health, European Union and OneRagtime.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech focused startup builder studio investing in the US & Europe | oneragtime.com | Paris, France | ||
Healthcare startups are accelerated and incubated through specialized programs. | 2015 | eithealth.eu | Munich, Germany | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for ExactCure
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ExactCure
8 people are tracked at ExactCure (4 in leadership, 4 in board & advisors).
| Name | Role | Group |
|---|---|---|
Frederic Dayan | Founder | Leadership |
Frédéric Dayan | CEO | Leadership |
Marc Salomon | Medical Director | Leadership |
Fabien Astic | Chief Business Development Officer | Leadership |
Jean-Luc Gouzé | Advisor | Board & advisors |
Philippe Beaune | Advisor | Board & advisors |
Anne Baille | Advisor | Board & advisors |
Eric Marée | Advisor | Board & advisors |
Complete people profiles for ExactCure
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ExactCure
3 dated milestones of ExactCure across 5 years, from founding to its latest funding, stage changes and deals.
- Founded ExactCure is founded.
- Funding First funding round of $47K.
- Funding Latest funding round, Grant, of $749K.
Web traffic of ExactCure
Websites that share an audience with ExactCure (exactcure.com).
Websites whose visitors overlap most with ExactCure. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
webtimemedias.com | webtimemedias.com | 100% | #5,335,481 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Exactcure
Complete news archive for ExactCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ExactCure
ExactCure was founded in 2016 and raised its 1st funding round 2 years after it was founded.
ExactCure is headquartered in Nice, France. It is registered at Nice, Provence-alpes-cote D'azur, France.
ExactCure is a funded company, having raised a total of $1.1M across 3 funding rounds to date. The company's 1st funding round was a Grant of $46.81K, raised on Jul 2018.
ExactCure was founded in 2016 in Nice, France, within the health technology sector. An AI-driven platform is being developed to enable patients to track drug behavior in their bodies without invasive diagnostics. Personalized responses are simulated using proprietary algorithms that analyze individual characteristics obtained from questionnaires. Operations focus on precision modeling for therapeutic outcomes in pharmaceutical applications.
ExactCure has 3 investors. Key investors include EIT Health, European Union, and OneRagtime.